[Image source=Yonhap News]

[Image source=Yonhap News]

View original image

The health authorities announced on the 12th that, as domestic Mpox cases continue to occur, they will form an Mpox advisory group to operate for two months in order to establish effective policies and responses for prevention.


Accordingly, the Mpox advisory group, composed of 10 private experts, held its first meeting on the 8th to discuss sharing domestic treatment experiences and revising clinical guidelines for medical personnel on Mpox, including strengthening criteria for administering therapeutics. The next meeting will address matters related to isolation and treatment of confirmed patients.


Meanwhile, in the first week of June (5th?11th), four additional domestic Mpox cases were confirmed, bringing the cumulative total to 106.


During this period, the confirmed cases included three Korean nationals and one foreigner, all male. The number of confirmed cases over the previous three weeks showed a slight decline: 6 → 11 → 10. However, the health authorities stated that continued surveillance and caution are necessary for high-risk groups.


The health authorities urged compliance with infection prevention guidelines when traveling abroad and advised caution regarding skin and sexual contact with strangers during festivals or events where close contact is expected.


Since vaccinations for high-risk groups began on the 8th of last month, as of the 11th of this month, 3,852 individuals have received the first dose and 248 have received the second dose. There have been a total of 120 reports (3.1%) of adverse reactions under active monitoring, mostly mild symptoms such as swelling and redness at the injection site.



The health authorities plan to additionally procure and supply 20,000 doses of the third-generation vaccine to expand vaccination for high-risk groups and prepare for increased demand for the second dose.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing